Pivotal CAR-T therapy cancer study published in the New England Journal of MedicinePR Newswire (press release)"For nearly a decade, John Theurer Cancer Center has been involved in CAR T-Cell research and the developments that led to the approval o… Continue reading
Myeloma Research NewsBioLineRx Readies Phase 3 Myeloma Trial to Mobilize Stem Cells for TransplantMyeloma Research NewsBioLineRx has launched a Phase 3 trial to assess if adding BL-8040 to standard treatment will improve the outflux of blood stem cells… Continue reading
Stem Cell Institute of America – December 22, 20179NEWS.comStem Cell Institute of America – December 22, 2017. Error loading player: No playable sources found. To find out if surgery-free, stem cell treatments can help relieve your joint pain inquire a… Continue reading
Genetic Engineering & Biotechnology News |
New technique could reveal immunotherapy targets, study finds
Science Daily Antigens are cumbersome to identify but critical to developing cancer immunotherapies, a type of treatment in which the host’s own immune system is trained to seek out and fight harmful or mutated cells. And while cancer vaccines are still largely a … Cancer Antigens Discerned by Seeing Them through Immune Cell EyesGenetic Engineering & Biotechnology News |
Drug Discovery & Development |
Janssen, Legend Biotech Strike Collaboration and License Agreement to Develop Investigational CAR–T Anti-Cancer …
Drug Discovery & Development Janssen Biotech, a Janssen Pharmaceutical Company of Johnson & Johnson, announced that it has entered into a worldwide collaboration and license agreement with Legend Biotech USA Inc. and Legend Biotech Ireland Limited (“Legend”), subsidiaries of … Janssen buys into Legend’s CART therapyPharmaTimes Chinese biotech firm Genscript’s shares jump by a third on US$350m Johnson & Johnson unit tie-upSouth China Morning Post |
Next Big Future |
CRISPR Hopes for ALS
GenomeWeb Researchers are testing whether gene editing might be possible treatment avenue for diseases like amyotrophic lateral sclerosis, Gizmodo reports. While most cases of ALS aren’t familial, a small portion is, and about 20 percent of those familial ALS … CRISPR extends lifespan of Lou Gehrigs disease mice by 25%Next Big Future First step toward CRISPR cure of Lou Gehrig’s diseaseEurekAlert (press release) Gene Editing Delays Disease Onset in ALS Model MiceAlzforum ALS News Today all 7 news articles » |